Pioneering Breakthrough Nerve Mapping and Ablation with the World’s First GPS for the Nervous System
Autonomix is pioneering a new frontier in neural signal detection with breakthrough technology that, for the first time ever, seeks to enable the sensing of nerve activity from within the body’s vasculature creating what could become the world’s first GPS for the nervous system.
This revolutionary capability lays the foundation for a powerful platform that could transform how neurological conditions are diagnosed and treated by precisely identifying and targeting overactive individual nerves.
Protected by exclusive rights to a rapidly growing global IP portfolio – including 18 patent families and more than 120 issued or pending applications worldwide – Autonomix is building a category-defining solution with the potential to unlock new treatments across cardiology, interventional pain management, pulmonology, gastroenterology, and more.
Autonomix: Engineering a New Era in Nerve-Based Therapies
First-Ever Ability to Read Nerve Activity and Guide Precision Energy Delivery with Real-Time Confirmation of Ablation Success
Extremely High Sensitivity Enables Detection and Differentiation of Neural Signals Below 5 Microvolts
Custom Sensing Antennae Array Processes Data in Immediate Proximity to the Nerve for Greater Signal Integrity and Resolution
Multichannel Sensing Provides 360-Degree Directional Targeting of Neuronal Structures
Unparalleled Sensitivity. Unmatched Precision.
Autonomix’s state-of-the-art custom-designed sensing antennae array has achieved detection thresholds below 5 µV, using prototype electrodes as small as 0.02 mm x 0.03 mm. This enables the capture of both high-fidelity signal resolution and spatial precision setting a new benchmark for the industry. This leap in sensitivity opens the door to a transformative method of transvascular nerve targeting, treatment, and confirmation: a novel approach that could address a wide spectrum of conditions.
Processing Power Brought Directly to the Nerves.
What sets Autonomix apart is our globally patent protected combination of ultra-sensitive nerve detection and a proprietary microchip that processes signals directly at the point of detection.
By embedding this advanced microchip technology within millimeters of the target nerve, localized processing minimizes signal degradation and preserves fidelity to enable real-time, high-resolution signal capture from within the vascular system. No other platform today offers this capability.
Lab-Grade Processing, Miniaturized.
Today’s nerve-sensing technologies rely on sending faint electrical signals through wires to external, room-sized processors, an approach that often loses critical data along the way.
Autonomix disrupts this model by compressing an entire lab into a 1×2 mm microchip with embedded sensing and processing electronics. Positioned just millimeters from the targeted nerve, our system enables unprecedented sensitivity, empowering physicians to precisely locate and ablate overactive nerves with confidence.
Three Breakthroughs. One Powerful Platform.
Ultra-Sensitive Detection with Proprietary Sensing Antenna Array
A sensing array that identifies faint signals from small, distributed nerve networks that conventional systems cannot detect.
Proprietary Microchip Signal Processing at the Source
Our proprietary chip processes nerve signals at the point of detection, preserving data integrity and allowing real-time clinical decision-making.
Miniaturized Lab-Grade Technology
A 1×2 mm chip delivers lab-grade performance from within the vasculature to enable unprecedented minimally invasive nerve mapping and ablation.